Author:
Hussein Hanan Khudhair,Aubead Nassrin Malik,Kzar Hamzah H.,Karim Yasir Salam,Amin Ali H.,Al-Gazally Moaed E.,Ahmed Tousief Irshad,Jawad Mohammed Abed,Hammid Ali Thaeer,Jalil Abduladheem Turki,Mustafa Yasser Fakri,Saleh Marwan Mahmood,Heydari Hafez
Abstract
Abstract
Background
Elevated lipids in umbilical cord blood affect fetal programming, leading to a higher risk of developing cardiovascular disease in later life. However, the causes of changes in the lipid profile of umbilical cord blood are not clear yet. This study aimed for the first time to determine the association of asprosin concentration with TAG, TC, HDL-C, LDL-C concentrations and TAG/HDL-C, TC/HDL-C, LDL-C/HDL-C and non-HDL-C/HDL-C ratio in umbilical cord blood as well as newborn anthropometric indices. This cross-sectional study was based on 450 mother- newborn pairs of a birth cohort study in Sabzevar, Iran. Multiple linear regression was used to estimate the association of lipid concentration and lipid ratios as well as birth weight (BW), birth length (BL), head circumference (HC) and chest circumference (CC) with asprosin in cord blood samples controlled for the relevant covariates.
Result
In fully adjusted models, each 1 ng/mL increase in asprosin was associated with 0.19 (95% CI 0.06, 0.31, P < 0.01), 0.19 (95% CI 0.10, 0.29, P < 0.01), 0.17 (95% CI 0.09, 0.25, P < 0.01), 0.17 (95% CI 0.09, 0.25, P < 0.01), 0.01 (95% CI 0.00, 0.013, P < 0.01), 0.01 (95% CI 0.01, 0.01, P < 0.01), 0.01 (95% CI 0.01, 0.01, P < 0.01) and 0.01 (95% CI 0.01, 0.01, P < 0.01) increase in TAG, TC, LDL-C, TAG/HDL-C, TC/HDL-C, LDL-C/HDL-C and non-HDL-C/HDL-C ratio respectively. Moreover, higher asprosin levels was positively associated with newborn BW, BL, HC and CC; however, these associations were not statistically significant.
Conclusion
Overall, our findings support the positive association between cord asprosin concentration and the development of atherogenic lipid profile in newborns. Further studies are needed to confirm the findings of this study in other populations.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference46 articles.
1. Benjamin EJ. Correction to: heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135(10):e646.
2. Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease. Circ Res. 2016;118(4):535–46.
3. Salari A, Roshanaei K, Rasoulian B, Khalili Fard J. Carvacrol attenuates disrupted lipid profile induced by organophosphates in male wistar rat: a comparative toxicity. J Chem Health Risks. 2021;11((Special Issue: Bioactive Compounds: Their Role in the Prevention and Treatment of Diseases)):121–8.
4. Napoli C, D’Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100(11):2680–90.
5. Casanueva V, Cid X, Chiang M, Molina M, Ferrada M, Perez R, et al. Lipids, lipoproteins and apolipoproteins in normal newborns. Rev Med Chil. 1998;126(9):1073–8.